Slides:

Advertisements

Similar presentations

Z.Vaseie MD Emergency Medicine Resident Guillain Barre Syndrom (GBS)  Group of autoimmune conditions involving demyelination and acute axonal degeneration.

Advertisements

The Tokyo Guidelines for Cholangitis

Progressive Ascending Paralysis in an Adult Male diagnosed with POEMS Syndrome: A Case Report Gilbert Siu, DO, PhD 1, Karen Gisotti, DO 1, and Jill Marple,

Neurology Chapter of IAP Guillain-Barre’. Neurology Chapter of IAP Guillain-Barre’ Syndrome Post-infectious polyneuropathy; ascending polyneuropathic.

Symptoms  Chief Complaint = “I am getting weak”  Painful sensations with increasing muscle weakness in both LE (started in ankles)  Prickly numbness.

Miller Fisher Syndrome A variant of Guillan Barré Syndrome Sarah I. Sheikh, BM BCh, MRCP.

Clinical Aspects of Peripheral Nerve and Muscle Disease Roy Weller Clinical Neurosciences University of Southampton School of Medicine.

Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.

Neuropathy Morning Report January 5 th,  Recognizing neuropathy  Classifying neuropathy  Myriad neuropathies  CIDP  Diagnosis  Spectrum of.

Guillain-Barre Syndrome

1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Edward J. Bastyr III, MD Promoting Clear Identification of Diabetic Peripheral.

Focal Peripheral Neuropathies Dr Jeremy Bland British Peripheral Nerve Society Charing Cross Hospital, 18 th October 2013.

Chronic Immune-Mediated Demyelinating Polyneuropathy

AIDP/CIDP Anal Pap Smear

Chronic Inflammatory Demyelinating Polyneuropathy By: Kyle Leato, SPTA.

Know what your EMG might miss!.  Speakers Tony Chiodo, MD Tony Chiodo, MD Timothy Dillingham, MD Timothy Dillingham, MD W. David Arnold, MD W. David.

© 2008 American Academy of Neurology Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory, genetic, and autonomic testing;

DoH IVIG Workshop Update, neurology usage and outcomes measurement

Epilepsy By Gabrielle Cramer. Brain Scan of an Individual with Frontal Lobe Epilepsy.

Peripheral neuropathy is the term for damage to nerves of the peripheral nervous system.nervesperipheral nervous system.

48-year-old man with ascending sensory deficits Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.

Epilepsy By Gabrielle Cramer. Brain Scan of an Individual with Frontal Lobe Epilepsy.

Nervous System Lymphoma n Background u Hodgkin’s disease F Rarely involves the nervous system u Non-Hodgkin’s lymphoma F Involves nervous system in 10%

Neurology Resident and Fellow Section 40 year old woman with left arm pain, numbness, and weakness Teaching NeuroImages © 2013 American Academy of Neurology.

To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE MORTALITY STATISTICS.

Basic Principles of Electrodiagnostic Medicine S.Mansoor Rayegani, M.D Professor Of Physical Medicine And Rehabilitation. Shahid Beheshti Medical University.

Group A – AHD Dr. Gary Greenberg

Department of Neurology, The 2nd affiliated hospital, kunming Medical College Yinfengqiong.

Epilepsy By Gabrielle Cramer. Brain Scan of an Individual with Frontal Lobe Epilepsy.

Journal club GUILLIAN BARRE SYNDROME IN ETHIOPIAN PATIENTS Zenebe Melaku,Guta Zenebe,Abera Bekele,2005,Ethiop Med J,43.

Dennis Bourdette, MD VA MS Center of Excellence-West and

Peripheral Neuropathy Clinical Management Course February 12, 2007

Peripheral nerve disease Peripheral nerve disease.

Politics, Illness, and Uncertainty Ray Teets, MD Myles Spar MD Melanie Gisler DO IM4US conference call 10/4/12 1 Lyme Disease.

CRITICAL ILLNESS NEUROMYOPATHY

Carpal Tunnel Syndrome. Anatomy Distribution Signs & Symptoms Pain – Worse at night Paraesthesia – Sparing the Thenar Eminence Weakness and Atrophy.

Celiac Disease: Neurological Manifestations in 2 undiagnosed patients Kogulavadanan Arumaithurai MD, Ashish Kapoor MD, Holli Horak MD, Katalin Scherer.

陳京瑜.  Inflammatory  Infectious  Hereditary  Acquired metabolic and toxic  Traumatic  Tumor.

Incidence, Risk Factors, and Short-Term Outcomes Associated with Hyponatremia in the Guillain-Barré Syndrome: A Nationwide Analysis of Hospitalizations.

Control # 2832 EE-27 T HE U NIVERSITY OF T EXAS H EALTH S CIENCE C ENTER AT H OUSTON MG Ramírez-Guzmán, AR Quiroz-Saavedra, H Ceja- Moreno, G Godoy-Brewer,

Chelsea Major, MPH Public Health Associate

Pattern Recognition of Neuropathic Disorders Richard J. Barohn, M.D. Chair, Department of Neurology Gertrude and Dewey Ziegler Professor of Neurology University.

Pattern Recognition of Myopathic Disorders

Volume 9, Issue 3, Pages (March 2010)

Chronic acquired demyelinating polyneuropathies

Diagnostic approach to patients with a limb-girdle pattern of weakness and suspected muscular dystrophy with an autosomal recessive inheritance pattern.

Immunomodulatory or immunosuppressive-induced neuropathies

Sensitivity of Brighton Criteria in diagnosing Guillain-Barre Syndrome in resource poor settings in Pakistan Ali Ghazanfar, Haider Ghazanfar 1: Federal.

Nat. Rev. Neurol. doi: /nrneurol

Fibromyalgia: A Chronic Widespread Neurologic Pain Condition

Figure 1. Absence of anti–neurofascin-155 (NF155) antibodies in combined central and peripheral demyelination (CCPD)‏ Absence of anti–neurofascin-155 (NF155)

Erb point in early diagnosis of Guillain-Barre syndrome in children

Nicholas J. Silvestri, M.D.

Figure 3 3D magnetic resonance neurography

Morning Report 10/5/17.

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the.

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Anatomical patterns of neuropathy

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Primary and secondary outcomes reported in multiple sclerosis (MS) disease-modifying therapy (DMT) clinical trials Primary and secondary outcomes.

A 47-year old HIV infected man with jerking of his right hand

III Meeting Neuroscienze Toscane

Figure 1 Clinical status and autoantibody titers in rituximab-treated patients with anti-CNTN1/NF155 chronic inflammatory demyelinating polyneuropathy.

Figure 2 Histopathological features in CIDP

PEREHHRAL NERVOUS SYSTEM

Figure 1 Classical pathway and lectin pathway activity in patients with multifocal motor neuropathy and controls Classical pathway (CP) activity (A) and.

The effect of PAD and infection on outcome of cast treatment

Figure 2 Time from incident ADS event to MS diagnosis

Frequency distribution of the number of fulfilled classification criteria for RA (ACR 1987) in relation to the proportion of positive anti-CCP antibodies.

Histograms showing periods until an improvement of one Hughes grade from onset. Histograms showing periods until an improvement of one Hughes grade from.

Presentation transcript:

Dyck PJ, Thomas PK. Peripheral Neuropathy. Philadelphia, PA:Elsevier Saunders, Jacobs BC, Rothbarth PH, Van der Meche, et al. The spectrum of antecedent infections in Guillain-Barre syndrome. A case-control study. Neurology 1998;51: Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre syndrome: an update. J Clin Neurosci 2009;16(6): Gordon PH, Wilbourne AJ. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol 2001;58: Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiganostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8: Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998;44: Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41: Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001:24: Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, Danon MJ, Donofrio P, Engel WK, England JD, Feldman EL, Freeman RL, Kinsella LJ, Lacomis D, Latov N, Menkes DL, Sander HW, Thomas FP, Triggs WJ, Windebank AJ. Wolfe GI; Neuropathy Association, Medical Advisory Committee. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerve Syst 2003;8:

Koski CL, Baumgarten M, Magder LS, Barohn RJ, Goldetein J, Graves M, Gorson K, Hahn AF, Hughes RA, Katz J, Lewis RA, Parry GJ, van Doorn P, Cornblat DR. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009;277:1-8. Van den bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.. Muscle Nerve 2004;29: Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision. J Peripher Nerv Syst 2010;15:1-9. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 1994;17: Olney RK, Lewis RA, Putnam TD, Campelione JV Jr, American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003:27: Van asseldonk JTH, Van den Berg LH, Van den Berg-Vos RM, Wieneke GH, Wokke JHJ, Franssen H. Demyelination and axon loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 2003;126: